Related Experiment Video
Updated: Dec 22, 2025

09:39
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
7.2K
A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system
Henrik Pedersen1, Rasmus K Jensen1, Annette G Hansen2
1Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
The Journal of Biological Chemistry
|May 8, 2020
Summary
A novel nanobody, hC3Nb2, effectively inhibits complement component C3 deposition across all pathways in humans and mice. This versatile inhibitor shows potential for studying complement activation in disease models.
Area of Science:
- Immunology
- Proteolytic cascades
- Innate immunity
Background:
- The complement system is crucial for innate immunity, tagging pathogens and cellular debris for clearance.
- Complement component C3 is central to complement activation.
- Dysregulated complement activation is linked to various human diseases, driving therapeutic development.
Purpose of the Study:
- To characterize a novel nanobody, hC3Nb2, as an inhibitor of complement component C3.
- To investigate the mechanism of inhibition and cross-reactivity of hC3Nb2.
Main Methods:
- Biochemical assays
- Surface plasmon resonance
- Negative stain electron microscopy
- Functional assays
Main Results:
- hC3Nb2 binds human C3 and its degradation products with low nanomolar affinity.
- hC3Nb2 inhibits C3 deposition across all complement pathways without interfering with Factor H/I regulation.
- The nanobody binds MG3 and MG4 domains of C3/C3b, inhibiting substrate-convertase interaction.
- hC3Nb2 demonstrates cross-reactivity, inhibiting lectin and alternative pathways in murine serum.
Conclusions:
- hC3Nb2 is a potent, general, and versatile inhibitor of human and murine complement cascades.
- Its cross-reactivity makes it valuable for analyzing complement activation in animal models of disease.
Related Concept Videos
Complement System
8.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
8.8K
Antibody Actions
2.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.2K
Antimicrobial Proteins
12.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.8K

